Small Extracellular Vesicles Orchestrate Cisplatin‐Induced Ototoxicity: Potential Biomarker and Targets Discovery
Abstract Cisplatin‐induced ototoxicity remains a clinical dilemma with limited mechanistic understanding and no food and drug administration (FDA)‐approved therapies. Despite emerging roles of small extracellular vesicles (sEV) in drug ototoxicity, their molecular cargo profiles and causal roles to...
Saved in:
| Main Authors: | Jingru Ai, Shasha Zhang, Mingchen Dai, Pei Jiang, Jingyuan Huang, Hairong Xiao, Yanqin Lin, Xujun Tang, Wei Tong, Jun He, Qiuyue Mao, Yintao Wang, Zixuan Ye, Tian Wang, Renjie Chai |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2025-08-01
|
| Series: | Advanced Science |
| Subjects: | |
| Online Access: | https://doi.org/10.1002/advs.202502627 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Reversible p53 inhibition prevents cisplatin ototoxicity without blocking chemotherapeutic efficacy
by: Nesrine Benkafadar, et al.
Published: (2016-10-01) -
Comparison of associations suggests mainly distinct pools of genetic risk factors contribute to cisplatin-induced hearing loss and hearing difficulty in the general population
by: Mohammad Shahbazi, et al.
Published: (2025-08-01) -
An overview of pharmacotherapy-induced ototoxicity
by: Natalie Schellack, et al.
Published: (2013-08-01) -
Investigation of Ototoxicity of Intratympanic 5-fluorouracil in Rats
by: Meltem Demirdağ Çevikkan, et al.
Published: (2022-12-01) -
Aminoglycoside-induced hearing deficits – a review of cochlear ototoxicity
by: Lucretia Petersen, et al.
Published: (2015-04-01)